These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 21888658)
21. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma. Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535 [TBL] [Abstract][Full Text] [Related]
22. Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma. Chen Y; Cui X; Wang D; Xia G; Xing M; Cheng L; Sheng L; Du X Front Oncol; 2021; 11():664397. PubMed ID: 35096557 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing. Ito M; Miyata Y; Hirano S; Kimura S; Irisuna F; Ikeda K; Kushitani K; Tsutani Y; Ueda D; Tsubokawa N; Takeshima Y; Okada M Oncotarget; 2017 Dec; 8(65):108936-108945. PubMed ID: 29312580 [TBL] [Abstract][Full Text] [Related]
24. Update on large cell neuroendocrine carcinoma. Hiroshima K; Mino-Kenudson M Transl Lung Cancer Res; 2017 Oct; 6(5):530-539. PubMed ID: 29114469 [TBL] [Abstract][Full Text] [Related]
25. Exploring imaging features of molecular subtypes of large cell neuroendocrine carcinoma (LCNEC). Hermans BCM; Sanduleanu S; Derks JL; Woodruff H; Hillen LM; Casale R; Hoesein FM; de Jong E; Berge DMHJT; Speel EJM; Lambin P; Gietema HA; Dingemans AC Lung Cancer; 2020 Oct; 148():94-99. PubMed ID: 32858338 [TBL] [Abstract][Full Text] [Related]
26. Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges. Andrini E; Marchese PV; De Biase D; Mosconi C; Siepe G; Panzuto F; Ardizzoni A; Campana D; Lamberti G J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268551 [TBL] [Abstract][Full Text] [Related]
27. Detection of tumor-specific autoantibodies in sera of patients with lung cancer. Nagashio R; Sato Y; Jiang SX; Ryuge S; Kodera Y; Maeda T; Nakajima T Lung Cancer; 2008 Dec; 62(3):364-73. PubMed ID: 18485524 [TBL] [Abstract][Full Text] [Related]
28. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung. Nasgashio R; Sato Y; Matsumoto T; Kageyama T; Hattori M; Iyoda A; Satoh Y; Ryuge S; Masuda N; Jiang SX; Saegusa M Lung Cancer; 2011 Dec; 74(3):405-10. PubMed ID: 21601304 [TBL] [Abstract][Full Text] [Related]
29. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study. Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526 [TBL] [Abstract][Full Text] [Related]
30. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?]. Schnabel PA; Junker K Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813 [TBL] [Abstract][Full Text] [Related]
31. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721 [TBL] [Abstract][Full Text] [Related]
35. Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer. Fujii K; Miyata Y; Takahashi I; Koizumi H; Saji H; Hoshikawa M; Takagi M; Nishimura T; Nakamura H Proteomics Clin Appl; 2018 Nov; 12(6):e1800015. PubMed ID: 29888431 [TBL] [Abstract][Full Text] [Related]
36. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung. Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939 [TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of laser-microdissected paraffin-embedded tissues: (1) Stage-related protein candidates upon non-metastatic lung adenocarcinoma. Kawamura T; Nomura M; Tojo H; Fujii K; Hamasaki H; Mikami S; Bando Y; Kato H; Nishimura T J Proteomics; 2010 Apr; 73(6):1089-99. PubMed ID: 19948256 [TBL] [Abstract][Full Text] [Related]
38. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses. Yeh YC; Chou TY J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337 [TBL] [Abstract][Full Text] [Related]
39. Analysis of 5-fluorouracil-related enzymes in pulmonary neuroendocrine carcinoma: differences in biological properties compared to epithelial carcinoma. Nagasaki T; Tsuchiya T; Tagawa T; Honda S; Yamasaki N; Miyazaki T; Hidaka S; Hayashi T; Nagayasu T Clin Lung Cancer; 2010 Nov; 11(6):412-22. PubMed ID: 21062732 [TBL] [Abstract][Full Text] [Related]
40. Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung. Matsumoto T; Ryuge S; Kobayashi M; Kageyama T; Hattori M; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y Int J Oncol; 2012 Jun; 40(6):1957-62. PubMed ID: 22426972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]